Add to MyPages

This page will be saved to Cincinnati Children's MyPages, a collection of your favorite places. You can view, organize, or delete your favorites at any time.

Page Title:

Description: (optional)

E-mail this page

(All fields required)

Recipient's e-mail address

Please enter a valid e-mail.

Your name

Please enter your name.

Your e-mail

Please enter a valid e-mail.

Share this on:

Sign into CCHMC

User Name

Password

New?

Forgot Password

Biographies

Find another Doctor or Researcher

High Res

Tanya E. Froehlich, MD

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-4611

Fax: 513-636-4402

Email: tanya.froehlich@cchmc.org

Show All

Specialties

Clinical Interests

ADHD; developmental and behavioral issues in underserved populations

Research Interests

ADHD; health care disparities

Education and Training

MD: Yale University, 1999.

Residency: Children's Hospital of Philadelphia, 2002.

Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center, 2005; General and Community Pediatrics National Research Service Award Fellow, Cincinnati Children's Hospital Medical Center, 2007.

Certification: Pediatrics, 2002; Developmental-Behavioral Pediatrics Subspecialty, 2006.

MS (Epidemiology): University of Cincinnati, 2007.

Publications

View PubMed Publications

Froehlich TE, Stein MA. Pharmacogenomics of ADHD. In M. Schwab, W. Kaschka, & E. Spina (Eds.). Pharmacogenomics in Psychiatry. Basil, Switzerland: Karger Medical and Scientific Publishers.

Rosen, PJ, Froehlich, TE, Langberg, JM, & Epstein, JN. Assessment of Comorbid Conditions. In B. Hoza & S. Evans (Eds.) Attention Deficit Hyperactivity Disorder: State of the Science and Best Practices (Volume 2). Kingston, NJ: Civic Research Institute.

Froehlich TE, McGough JJ, Stein MA. Progress and Promise of ADHD Pharmacogenetics. CNS Drugs. 2010; 24: 99-117.

Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein JN. Clinical utility of the Vanderbilt ADHD Rating Scale for ruling out comorbid learning disorders. Pediatrics. 2010 Nov;126(5):e1033-8.

Froehlich TE, McGough JJ, Stein MA. Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs. 2010 Feb 1;24(2):99-117. doi: 10.2165/11530290-000000000-00000. Review.

Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS. Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics. 2009 Dec;124(6):e1054-63.

Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing children with ADHD in primary care settings. Expert Rev Neurother. 2008 Apr;8(4):627-41. Review.

Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007 Sep;161(9):857-64.

Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children. Biol Psychiatry. 2007 Aug 1;62(3):243-9. Epub 2007 Jan 17.

Grants

Medication Response in Children with Predominantly Inattentive Type ADHD. Principal Investigator. National Institute of Mental Health Career Development (K23) Award. 2009 - 2014. #K23MH083881.